Literatur
Tagami T, Matsui H, Horiguchi H et l.. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Eur Respir J. 2014 Oct 16. pii: erj00815-2014. [Epub ahead of print]
Snijders D, Daniels JM, de Graaff CS et al. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 2010; 181: 975–982.
Meijvis SC, Hardeman H, Remmelts HH et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377: 2023–2030.
Literatur
Blum CA, Nigro N, Briel M et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015. [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Budweiser, S. Rascher stabil mit systemischen Steroiden. Pneumo News 7, 26–27 (2015). https://doi.org/10.1007/s15033-015-0099-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-015-0099-6